127 related articles for article (PubMed ID: 8598235)
1. Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia vera.
Carneskog J; Wadenvik H; Fjälling M; Kutti J
Eur J Haematol; 1996 Mar; 56(3):158-62. PubMed ID: 8598235
[TBL] [Abstract][Full Text] [Related]
2. Measurement of spleen size using gamma camera scintigraphy in essential thrombocythaemia.
Revesz P; Carneskog J; Wadenvik H; Jarneborn L; Kutti J
Eur J Haematol; 1993 Sep; 51(3):141-3. PubMed ID: 8405328
[TBL] [Abstract][Full Text] [Related]
3. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
Johansson P; Safai-Kutti S; Lindstedt G; Suurküla M; Kutti J
Acta Haematol; 2002; 108(1):1-7. PubMed ID: 12145459
[TBL] [Abstract][Full Text] [Related]
4. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
[TBL] [Abstract][Full Text] [Related]
5. Spleen sizing by ultrasound in polycythaemia and thrombocythaemia: comparison with SPECT.
Messinezy M; Macdonald LM; Nunan TO; Westwood NB; Chinn S; Pearson TC
Br J Haematol; 1997 Jul; 98(1):103-7. PubMed ID: 9233571
[TBL] [Abstract][Full Text] [Related]
6. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
[TBL] [Abstract][Full Text] [Related]
7. Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage.
Chou YS; Gau JP; Yu YB; Pai JT; Hsiao LT; Liu JH; Hong YC; Liu CY; Yang CF; Chen PM; Chiou TJ; Tzeng CH
Eur J Haematol; 2013 Mar; 90(3):228-36. PubMed ID: 23281576
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2000 Mar; 64(3):188-93. PubMed ID: 10997885
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF).
Mascarenhas J; Lu M; Li T; Petersen B; Hochman T; Najfeld V; Goldberg JD; Hoffman R
Br J Haematol; 2013 Apr; 161(1):68-75. PubMed ID: 23330839
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases.
Branehög I; Ridell B; Swolin B; Weinfeld A
Scand J Haematol; 1975 Dec; 15(5):321-32. PubMed ID: 1060175
[TBL] [Abstract][Full Text] [Related]
11. The red cell mass, plasma erythropoietin and spleen size in apparent polycythaemia.
Carneskog J; Safai-Kutti S; Suurküla M; Wadenvik H; Bake B; Lindstedt G; Kutti J
Eur J Haematol; 1999 Jan; 62(1):43-8. PubMed ID: 9918311
[TBL] [Abstract][Full Text] [Related]
12. Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutation.
Hexner E; Roboz G; Hoffman R; Luger S; Mascarenhas J; Carroll M; Clementi R; Bensen-Kennedy D; Moliterno A
Br J Haematol; 2014 Jan; 164(1):83-93. PubMed ID: 24903629
[TBL] [Abstract][Full Text] [Related]
13. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia.
Carneskog J; Kutti J; Wadenvik H; Lundberg PA; Lindstedt G
Eur J Haematol; 1998 May; 60(5):278-82. PubMed ID: 9654156
[TBL] [Abstract][Full Text] [Related]
14. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
[TBL] [Abstract][Full Text] [Related]
15. The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity.
Zhang B; Lewis SM
Eur J Haematol; 1989 Jul; 43(1):63-6. PubMed ID: 2767243
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera-A matched nationwide population-based study.
Enblom-Larsson A; Renlund H; Andréasson B; Holmberg H; Liljeholm M; Själander A
Br J Haematol; 2024 May; 204(5):1740-1751. PubMed ID: 38351734
[TBL] [Abstract][Full Text] [Related]
17. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Lindstedt G; Stockelberg D; Wadenvik H; Kutti J
Leuk Lymphoma; 2001 May; 41(5-6):579-84. PubMed ID: 11378575
[TBL] [Abstract][Full Text] [Related]
18. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
[TBL] [Abstract][Full Text] [Related]
19. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
20. Polycythaemia vera and essential thrombocythaemia: current treatment strategies.
Penninga EI; Bjerrum OW
Drugs; 2006; 66(17):2173-87. PubMed ID: 17137402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]